Regen BioPharma, Inc. filed its 10-K on Nov 15, 2022 for the period ending Sep 30, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.59 USD | +1.72% | +2.59% | -37.89% |
1st Jan change | Capi. | |
---|---|---|
-37.89% | 2.46M | |
+2.93% | 108B | |
-1.48% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- RGBP Stock
- News Regen BioPharma, Inc.
- Regen BioPharma, Inc. Auditor Raises 'Going Concern' Doubt